We are live on ! Find out more
NXGN

NextGen Healthcare, Inc. Common Stock

Delisted

NXGN was delisted on the 8th of November, 2023.

165 hedge funds and large institutions have $908M invested in NextGen Healthcare, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 58 increasing their positions, 58 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

203% more call options, than puts

Call options by funds: $6.39M | Put options by funds: $2.11M

42% more capital invested

Capital invested by funds: $638M → $908M (+$271M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 58

2% less funds holding

Funds holding: 169165 (-4)

17% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 18

Holders
165
Holders Change
-4
Holders Change %
-2.37%
% of All Funds
3.78%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
58
Reduced
58
Closed
18
Calls
$6.39M
Puts
$2.11M
Net Calls
+$4.28M
Net Calls Change
+$1.46M
Name Holding Trade Value Shares
Change
Change in
Stake
ZCM
126
Zebra Capital Management
Connecticut
$200K -$14.2K -897 -8%
EP
127
Elkfork Partners
Oregon
$200K
LIA
128
LS Investment Advisors
Michigan
$170K -$4.16K -263 -3%
GHCM
129
Glen Harbor Capital Management
California
$165K
Bank of Montreal
130
Bank of Montreal
Ontario, Canada
$162K +$20.4K +1,290 +18%
BNP Paribas Financial Markets
131
BNP Paribas Financial Markets
France
$157K -$134K -8,471 -51%
MCIM
132
Meadow Creek Investment Management
Georgia
$130K
Macquarie Group
133
Macquarie Group
Australia
$129K +$39.5K +2,500 +61%
MAM
134
Meeder Asset Management
Ohio
$123K +$8.63K +546 +9%
RCM
135
Riverhead Capital Management
Delaware
$107K
FCM
136
Flinton Capital Management
Pennsylvania
$94K
AIP
137
Ameritas Investment Partners
Nebraska
$89K
Simplex Trading
138
Simplex Trading
Illinois
$80K +$49.2K +3,115 +314%
US Bancorp
139
US Bancorp
Minnesota
$75K +$56.7K +3,586 +1,470%
PCM
140
Prelude Capital Management
New York
$70K -$170K -10,731 -75%
AG
141
Advisor Group
Arizona
$68K
Zurich Cantonal Bank
142
Zurich Cantonal Bank
Switzerland
$63K
CG
143
Cutler Group
California
$56K +$30.9K +1,955 +202%
Loomis, Sayles & Company
144
Loomis, Sayles & Company
Massachusetts
$39K -$12K -758 -28%
PNC Financial Services Group
145
PNC Financial Services Group
Pennsylvania
$33K +$7.9K +500 +42%
Royal Bank of Canada
146
Royal Bank of Canada
Ontario, Canada
$22K +$7.67K +485 +73%
RA
147
Royce & Associates
New York
$20K +$3.43K +217 +27%
CF
148
Centaurus Financial
California
$20K +$16K +1,014 New
JA
149
JOYN Advisors
Georgia
$19K -$19.3K -1,223 -56%
LTFS
150
Ladenburg Thalmann Financial Services
Florida
$18K

NXGN Hedge Fund Activity: Q2 2018 in Review

165 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in NextGen Healthcare, Inc. Common Stock (NXGN) for Q2 2018, worth a combined $908M — up 42% from $638M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of NXGN and 15 opened new positions — a net loss of 3 holders — while 58 trimmed existing stakes and 58 added.

The largest buyer was Elk Creek Partners, opening a new position worth an estimated $12.5M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $6.05M sold.

  • 165 institutional investors held NextGen Healthcare, Inc. Common Stock (NXGN) as of Q2 2018, down from 169 in Q1 2018.
  • Funds reported $908M of NextGen Healthcare, Inc. Common Stock stock for Q2 2018, up 42% quarter-over-quarter.
  • 15 funds opened new NextGen Healthcare, Inc. Common Stock positions in Q2 2018 and 18 closed out, a net change of -3 holders.
  • The largest NextGen Healthcare, Inc. Common Stock buyer in Q2 2018 was Elk Creek Partners, an estimated $12.5M added.
  • The largest NextGen Healthcare, Inc. Common Stock seller in Q2 2018 was PFM Health Sciences, an estimated $6.05M sold.

Based on aggregated 13F filings for Q2 2018.